Allergic rhinitis, more commonly known as hay fever, is the most common form of allergy and is characterized by inflammation of the nose and airways after exposure to an airborne allergen. People with allergic rhinitis may experience a runny or blocked nose, sneezing, an itchy throat, watery eyes, or headaches.
Other forms of allergies can manifest as rashes, itching, redness, or digestive problems. Whether the immune system is reacting to dust, cats, freshly cut grass, pollen, or certain foods, the body produces an excessive immune response, composed of numerous pro-inflammatory chemicals. One of these chemicals is known as histamine, and it is often responsible for uncomfortable allergy symptoms.
Quercetin is a naturally occurring flavonoid compound found most abundantly in apples, onions, tea, and berries. Clinically, quercetin is best known for its ability to stabilize mast cells, prevent histamine release, and prevent and manage allergic reactions, including allergic rhinitis. An additional benefit of quercetin is its cardioprotective nature. It helps prevent the oxidation of LDL cholesterol, a process that triggers blood vessel stiffening in heart disease. Quercetin has also been shown to have gastroprotective, anti-cataract, anti-inflammatory, and antiviral effects. A combination of its immune-modulating abilities and these actions may explain why research has shown it can be effective in cases of chronic nonbacterial prostatitis.
With all this in mind, there is a well-known problem with quercetin, and that is its low bioavailability. Some research suggests that the bioavailability of oral quercetin may be as low as 1%. In addition to the obvious local benefits of quercetin on the digestive tract lining and the subsequent systemic health benefits resulting from increased immune regulation, there is good reason to improve the bioavailability of quercetin to provide even more health benefits at the tissue level. CytoMatrix Liposomal Quercetin provides quercetin in a micellar liposome formulation, offering a solution to the low bioavailability of a standard quercetin supplement.
Liposomal delivery systems were originally developed to optimize the pharmacokinetics and efficacy of pharmaceutical drugs. These same principles have now been applied to natural health ingredients. A liposome consists of a single- or multi-layer phospholipid structure with an aqueous core. Active ingredients can be placed within the aqueous core or within the phospholipid bilayer, where they are protected from various enzymatic and digestive processes. Ultimately, liposomes improve the bioavailability of active ingredients.
However, not all liposomal deliveries are created equal. Liposomes are several hundred nanometers in size, meaning there is still a significant amount of digestion that must occur to reduce the surface area and allow for proper absorption. Micelles, on the other hand, are significantly smaller and can be absorbed directly at a size of around 20 nanometers.
Cyto-Matrix Liposomal Quercetin utilizes a unique, patented Cyto-Sorb technology to create a stable, multi-layered liposome with additional micellar delivery of quercetin. These methods allow for micronutrient stability and enhanced bioavailability, while also promoting the delivery of active ingredients to intestinal absorption sites in a sustained-release manner.
Cyto-Sorb liposomal formulas are produced through a two-phase emulsion process using phosphatidylcholine from non-GMO sunflower, vitamin E, and organic coconut vegetable glycerin. Potassium bicarbonate is strategically added to stabilize the active ingredient, prevent oxidation, and enhance flavor. Cyto-Matrix Liposomal Quercetin provides 166.6 mg of quercetin per teaspoon in a delicious pineapple flavor for improved compliance, to deliver enhanced antihistamine and anti-inflammatory responses.